Skip to main content
Print Save

LU B 22 (Fenofibrate 145 mg)

Pill with imprint LU B 22 is White, Elliptical/Oval and has been identified as Fenofibrate 145 mg. It is supplied by Lupin Pharmaceuticals, Inc.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia; hyperlipoproteinemia type iv, elevated vldl; hyperlipoproteinemia type iib, elevated ldl vldl and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 145 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for LU B 22

Fenofibrate 145 mg LU B 22
Fenofibrate 145 mg LU B 22
Fenofibrate 145 mg LU B 22
Fenofibrate 145 mg LU B 22

Fenofibrate

Imprint
LU B 22
Strength
145 mg
Color
White
Size
18.00 mm
Shape
Elliptical/Oval
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Lupin Pharmaceuticals, Inc.
Inactive Ingredients
crospovidone, hypromellose 2910 (3 mPa.s), lactose monohydrate, magnesium stearate, polacrilin potassium, polyethylene glycol, polyvinyl alcohol, silicon dioxide, sodium lauryl sulfate, sucrose, magnesium silicate, titanium dioxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
68180-0361 Lupin Pharmaceuticals, Inc.
68084-0636 Amerisource Health Services
Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer